A carregar...
Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers
Pathologic complete response (pCR) after neoadjuvant chemotherapy is considered a suitable surrogate marker of treatment efficacy in patients with triple-negative breast cancers (TNBCs). However, the molecular mechanisms underlying pCR as a result of such treatment remain obscure. Using real-time PC...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356581/ https://ncbi.nlm.nih.gov/pubmed/27626685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11900 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|